Bisabolol Research Dashboard
Clinical Studies
0
Clinical Meta-analyses
2
Double-blind Clinical Trials
1
Clinical Trials
Pre-Clinical Studies
4
Animal Studies
5
Laboratory Studies
What am I missing as a non-subscriber?
To see a full dashboard with study details and filtering, go to our DEMO page.
As a subscriber, you will be able to access dashboard insights including chemotype overviews and dosing summaries for medical conditions and organ system and receptor breakdowns for cannabinoid and terpene searches. Study lists present important guidance including dosing and chemotype information with the ability to drill down to the published material. And all outputs are fully filterable, to help find just the information you need. Stay up-to-date with the science of cannabis and the endocannabinoid system with CannaKeys.
CannaKeys has 14 studies associated with Bisabolol.
Here is a small sampling of Bisabolol studies by title:
- Effectiveness of the sesquiterpene (-)-α-bisabolol in dogs with naturally acquired canine leishmaniosis: an exploratory clinical trial
- Clinical efficacy of new α-bisabolol mouthwashes in postoperative complications of maxillofacial surgeries: a randomized, controlled, triple-blind clinical trial
- Cyclodextrin Conjugated α-Bisabolol Suppresses FAK Phosphorylation and Induces Apoptosis in Pancreatic Cancer
- Anticancer effect of terpenes: focus on malignant melanoma
- Cannabis terpenes display variable protective and anti-aggregatory actions against neurotoxic β amyloid in vitro: highlighting the protective bioactivity of α-bisabolol in motorneuronal-like NSC-34 cells
Components of the Bisabolol Research Dashboard
- Top medical conditions associated with Bisabolol
- Proven effects in clinical trials for Bisabolol
- Receptors associated with Bisabolol
- Individual study details for Bisabolol
Ready to become a subscriber? Go to our PRICING page.
Filter Terpene
Members can filter by the following criteria:
- Study Type
- Organ Systems
- Cannabinoids & Endocannabinoids
- Receptors
- Ligands
- Study Result
- Year of Publication
Overview - Bisabolol
What is Bisabolol?
Bisabolol is a sesquiterpene occurring in significant amounts in several plant species, such as Psidium guajava (guava), Matricaria chamomilla (German chamomile), and cannabis.
Is Bisabolol safe?
Its concentrated form is a clear, colorless liquid that may cause skin irritation and allergic reactions.
Other Names
IUPAC Name: (2R)-6-methyl-2-[(1R)-4-methylcyclohex-3-en-1-yl]hept-5-en-2-ol
Source–PubChem
Scent Description
Fruity, nutty aroma with hints of coconut.
Source–PubChem
Natural Sources
Psidium guajava (guava), Matricaria chamomilla (German chamomile), Cannabis.
Cannabis Strains High in Bisabolol
Girl Scout Cookies
Bisabolol Properties and Effects
Bisabolol may have the following properties and effects:
- Analgesia
- Antinociceptive (B. Amora-Silva et al., 2019)
- Anti-inflammatory (B. Amora-Silva et al., 2019; A. Licari et al., 2017)
- Anti-amyloid (against neurotoxic beta-amyloid) (J. Laws Iii et al., 2022)
- Anticancer
- Anti-metastatic (in pancreatic cancer cells) (M. Uno et al., 2016; Y. Murata et al., 2017)
- Anti-tumor (in pancreatic cancer cells) (M. Kano et al., 2023; T. Seki et al., 2011)
- Apoptotic (in pancreatic cancer cells) (M. Kano et al., 2023)
- Antioxidant (E. Ramazani et al., 2022)
- Neuroprotective (H. Javed et al., 2020)
- Cardio-protective (M. Nagoor Meeran et al., 2020)
- Skin-protective
- Wound healing (B. Amora-Silva et al., 2019)
- Anti-pruritic
- Depigmenting (skin lightening) agent (J. Lee et al., 2010)
- Antimicrobial (B. Amora-Silva et al., 2019)
- Candida albicans (F. Galvão Rodrigues et al., 2018)
- Candida krusei (F. Galvão Rodrigues et al., 2018)
- Candida tropicalis (F. Galvão Rodrigues et al., 2018)
- Staphylococcus aureus (F. Galvão Rodrigues et al., 2018)
- Anti-parasitical
- Leishmaniosis (effective in dogs) (V. Corpas-Lopez et al., 2018)
- Gastro-protective (N. Moura Rocha et al., 2011)
- Nephroprotective (T. Lima Sampaio et al., 2016)
- Synergistic analgesia with Tetradrine (may reduce brain cancer metastasis) (L. Jui-Feng et al., 2022)
Bisabolol Receptor Binding
Endocannabinoid System (ECS) and Bisabolol:
N/A
Endocannabinoidome (eCBome) and Bisabolol:
- A3 (Adenosine receptor site 3) (F. Brackmann Mendes et al., 2017)
- Ca+ (Voltage-gated sodium channel Ca+ channels)
- Cav3.2 T-type calcium channels (inhibits) (V. Gadotti et al., 2021)
- FAK (focal adhesion kinase is involved in how cells stick together) (Bisabolol inhibits FAK phosphorylation-induces anticancer apoptosis) (M. Kano et al., 2023)
- KISS1r (Kisspeptin receptor aka GPR54) (bisabolol activates with potential therapeutic potential for pancreatic cancer) (M. Uno et al., 2016)
- MARK (Mitogen-activated protein kinase) (bisabolol inhibits) (B. Venkataraman et al., 2022)
- PPAR-γ (Peroxisome Proliferator-Activated Receptor-γ) (bisabolol stimulates PPAR-γ expression) (B. Venkataraman et al., 2022)
Disclaimer
Information on this site is provided for informational purposes only and is not meant to substitute for the advice provided by your own licensed physician or other medical professional. You
should not use the information contained herein for diagnosing or treating a health problem or disease. If using a product, you should read carefully all product packaging. If you have or suspect that you have a
medical problem, promptly contact your health care provider.
Information on this site is based on scientific studies (human, animal, or in vitro), clinical experience, or traditional usage as cited in each article. The results reported may not necessarily occur in all individuals.
For many of the conditions discussed, treatment with prescription or over-the-counter medication is also available. Consult your physician, nutritionally oriented health care practitioner, and/or pharmacist for
any health problem and before using any supplements or before making any changes in prescribed medications.